Viewing Study NCT03684005


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-02-28 @ 6:34 PM
Study NCT ID: NCT03684005
Status: COMPLETED
Last Update Posted: 2021-03-02
First Post: 2018-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MyPatientPal: An App to Help Patients Manage Their Cancer Care
Sponsor: Felicity Harper
Organization:

Study Overview

Official Title: MyPatientPal: An App to Help Patients Manage Their Cancer Care
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: MyPatientPal was developed in collaboration with both patient and oncologist stakeholders, is designed to facilitate such patient self-management through the daily reporting of side effects and medications.
Detailed Description: MyPatientPal is a patient app that is designed to help patients track and manage treatment side effects and medication adherence on a daily basis. Side effects (e.g., pain, fatigue, diarrhea, nausea) can be physically and emotionally debilitating, and when uncontrolled, can cause treatment complications, resulting in unscheduled care costs, patient out-of-pocket costs, and delays or discontinuation of treatment. The app allows personalization of daily entries such that patients can select the specific medications and dosage and side effects (using items from the NCI Common Terminology Criteria for Adverse Events) that they and/or their providers want to track. A charting feature provides an easy-to-read display of patients' daily reports, summarizing the intensity and frequency of side effects and medication use either by week or by month. These reports can also be printed out and shared with providers.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: